New Chairman at MIP Technologies

The Medicon Valley Academy member MIP Technologies, appoints Professor Hans Sievertsson as new Chairman of the Board. The previous Chairman, Torben Jörgensen, currently serving as CEO at Biotage will remain as a board member of MIP Technologies and continue to contribute his experience from many years as CEO of life science companies.

Hans Sievertsson has a wealth of experience in the life sciences industry. He has held positions such as Vice President and head of R&D at Kabi, President of Nobel Kemi AB, Group Vice President and Corporate Head of R&D at KabiPharmacia AB and Pharmacia AB and Vice President Corporate Development of Pharmacia Corporation. In 2001 Hans Sievertsson retired from Pharmacia Corp. Hans Sievertsson is the Chairman of SwedenBio and the Swedish Academy of Pharmaceutical Sciences (APS). He also serves on the boards of A. Carlsson Research AB, Innate Pharmaceuticals AB (publ) and Catella Healthcare Investments AB.

"With his long experience in the Pharmaceutical industry Hans Sievertsson will add a new dimension to our developing business strategy and provide valuable experience of this important industrial sector as we move forward", said Anthony Rees the CEO.

"What attracted me to MIP Technologies is the potential of its technology and current products. Based on the molecularly imprinted polymers, the product pipeline will be used both for analytical and process scale applications", said Hans Sievertsson.

Source: Press-release MIP Technologies 07.09.2006.

Visit the MIP Technologies homepage.